DNOW’s MRC Global merger targets $75 million of synergies, with a 2029 bull case of $30 to $32 per share driven by cash flow and rerating.
YT Yet Another Value Podcast Aug 14 10 clicks
CoreWeave and Nebius cite AI compute shortages and higher-priced GPU renewals, but older-chip utilization and depreciation vary across…
S MBI Deep Dives Aug 14 9 clicks
Macy’s and Kohl’s face renewed short cases as their recent reratings ignore fading store-refresh gains, credit-card earnings exposure and…
S Bristlemoon Capital Aug 13 10 clicks
Options strategies will manage portfolio risk after Meta, Alphabet and Amazon calls drove gains, while Lululemon LEAPs produced an 80% loss.
S MBI Deep Dives Aug 13 8 clicks
Zoetis’s U.S. companion-animal revenue fell 6% as dermatology competition drove rebates and discounts, pushing full-year net pricing to…
S scuttleblurb Aug 13 10 clicks
Copart faces a near-term lift from pricier AV repairs and total losses, but shrinking accident volumes could eventually force its…
S Bearhold Research Aug 13 10 clicks
GFL’s proposed acquisition of Secure follows 19% revenue growth at Secure and 14.8% EBITDA growth at GFL, with Permian produced-water and…
S 310 Value’s Newsletter Aug 12 12 clicks
UWMC booked a roughly $600 million Q2 hedging loss tied to TWO months after the deal collapsed, contributing to an expensive capital raise.
S Yet Another Value Blog Aug 11 12 clicks
Glenn Schorr and Ken Worthington discuss risks in private-credit software loans, agentic AI at retail brokers, crypto use cases and bank…
YT Steve Eisman Aug 10 14 clicks
Figma raised its 2026 revenue growth guide to 39%, but a roughly 1% sequential 3Q outlook and unchanged $125-135 million operating-income…
S MBI Deep Dives Aug 10 11 clicks
ZTS · long Zoetis, the animal prescription-medicines company, is presented as a long investment despite concerns around its 2026 and 2027 outlook.
BL Value Investors Club May 8 4 clicks
Danaher posted 3.0% core revenue growth in 2Q’26, with LTM adjusted EBITA flat at $7.1 billion since 2Q’24 despite a mid-20s earnings…
S MBI Deep Dives Jul 22 4 clicks
TSMC’s 2Q 2026 operating margin exceeded 60% as AI-driven demand for advanced chips pushed profitability beyond the prior cycle’s…
S MBI Deep Dives Jul 17 4 clicks
ASML’s 2Q’26 commentary signals a shift from measured pricing toward flexing its chip-equipment pricing power.
S MBI Deep Dives Jul 16 3 clicks
Infineon’s power semiconductors stand to benefit from AI data centers shifting to 800VDC power delivery, though its sharp rerating to…
S Bristlemoon Capital Jun 4 2 clicks
Universal Health Services faces a $432 million–$480 million annual Medicaid supplemental-payment hit by 2032, offset by behavioral-health…
S Bearhold Research Jun 4 4 clicks
Baron’s BARAX and BGAFX hold SpaceX at a $1.25 trillion valuation, creating a potential NAV uplift if its IPO prices higher.
S Cluseau Research Jun 3 6 clicks
Spotify and Universal Music Group will offer licensed AI song covers and remixes as a Premium add-on, with artist opt-in and royalty…
S scuttleblurb Jun 1 6 clicks
Ivonescimab plus chemotherapy extended median overall survival by 4.2 months versus Tevimbra plus chemotherapy in HARMONI-6, challenging…
S John Hempton's Newsletter May 31 9 clicks
Bristol Myers Squibb’s bear case centers on patent-cliff revenue losses, debt, and failed drug investment after $28.3 billion of 2019–23…
S John Hempton's Newsletter May 26 9 clicks